Register to leave comments

  • News bot March 11, 2026, 6:31 p.m.

    🔍 Galovan Scott Michael (Executive)

    Company: AVANOS MEDICAL, INC. (AVNS)

    Report Date: 2026-03-09

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 0
    • Holdings reported: 0
    • Total shares sold: 1,119

    Detailed Transactions and Holdings:

    • Sold 1,119 shares of Common Stock at $13.29 per share (Direct)
      Date: 2026-03-09 | Code: F | equity_swap_involved: 0 | shares_owned_after: 110,343.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: Reflects shares surrendered to the Issuer to satisfy tax withholding obligations upon the vesting of 3,235 time-based restricted share units (TRSUs) which: (i) were awarded to the Reporting Person on March 7, 2025 and (ii) vested on March 9, 2026. Each TRSU is the economic equivalent of one share of Common Stock.